Allmed Medical Products Co., Ltd
SZSE:002950.SZ
9.17 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 397.037 | 522.205 | 678.463 | 1,302.2 | 242.527 | 309.597 | 200.292 | 307.3 | 185.124 | 239.03 |
| Short Term Investments
| 96.822 | 264.632 | 8.137 | 35.633 | 1.056 | 0.728 | -6.916 | 3.163 | 2.353 | 6.773 |
| Cash and Short Term Investments
| 493.859 | 786.836 | 686.6 | 1,337.833 | 243.583 | 310.325 | 200.292 | 310.463 | 187.477 | 245.803 |
| Net Receivables
| 493.279 | 652.856 | 621.363 | 533.208 | 554.544 | 442.221 | 240.057 | 254.836 | 314.468 | 249.064 |
| Inventory
| 707.208 | 877.327 | 846.629 | 707.285 | 708.608 | 565.362 | 442.594 | 318.245 | 409.662 | 312.751 |
| Other Current Assets
| 85.2 | 81.94 | 88.508 | 257.942 | 156.518 | 123.045 | 80.718 | 76.915 | 85.593 | 72.247 |
| Total Current Assets
| 1,779.545 | 2,398.96 | 2,243.1 | 2,836.268 | 1,663.253 | 1,440.954 | 963.661 | 960.459 | 997.199 | 879.866 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 1,987.688 | 2,019.533 | 1,603.954 | 1,259.572 | 1,215.421 | 1,171.289 | 987.694 | 738.023 | 673.233 | 678.478 |
| Goodwill
| 98.095 | 98.095 | 25.994 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 202.661 | 213.584 | 234.746 | 219.533 | 161.232 | 184.807 | 188.83 | 111.355 | 111.836 | 76.671 |
| Goodwill and Intangible Assets
| 300.756 | 311.679 | 260.74 | 219.533 | 161.232 | 184.807 | 188.83 | 111.355 | 111.836 | 76.671 |
| Long Term Investments
| 951.592 | 610.562 | 750.545 | 367.606 | 8.544 | 8.872 | 16.516 | 6.437 | 7.247 | 19.755 |
| Tax Assets
| 56.189 | 48.876 | 64 | 44.139 | 45.669 | 43.638 | 41.413 | 18.851 | 18.715 | 18.589 |
| Other Non-Current Assets
| 8.547 | 357.898 | 82.49 | 128.963 | 61.597 | 50.627 | 74.488 | 62.419 | 39.968 | 77.573 |
| Total Non-Current Assets
| 3,304.773 | 3,348.547 | 2,761.729 | 2,019.813 | 1,492.462 | 1,459.233 | 1,308.941 | 937.085 | 850.999 | 871.066 |
| Total Assets
| 5,084.318 | 5,747.507 | 5,004.829 | 4,856.08 | 3,155.716 | 2,900.187 | 2,272.602 | 1,897.544 | 1,848.198 | 1,750.932 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 311.103 | 897.316 | 253.856 | 143.867 | 107.554 | 135.898 | 181.686 | 108.912 | 75.357 | 64.77 |
| Short Term Debt
| 819.274 | 821.344 | 1,160.923 | 1,086.068 | 396.246 | 846.783 | 482.492 | 442.876 | 481.694 | 753.169 |
| Tax Payables
| 6.289 | 15.412 | 48.866 | 99.551 | 27.581 | 37.238 | 45.562 | 62.995 | 6.174 | 2.555 |
| Deferred Revenue
| 64.844 | 129.319 | 158.436 | 234.595 | 109.924 | 37.238 | 103.947 | 190.778 | 159.396 | 97.976 |
| Other Current Liabilities
| 130.246 | 218.948 | 65.376 | 0.712 | 6.651 | 84.781 | 1.322 | 1.724 | 3.58 | 3.127 |
| Total Current Liabilities
| 1,325.467 | 2,066.927 | 1,638.591 | 1,465.242 | 620.375 | 1,104.7 | 769.448 | 744.29 | 720.028 | 919.042 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 146.315 | 111.45 | 128.204 | 100 | 186.742 | 228 | 154 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 191.937 | 189.682 | 292.169 | 220.452 | 197.282 | 194.463 | 192.833 | 89.07 | 84.16 | 52.761 |
| Deferred Tax Liabilities Non-Current
| 199.708 | 243.13 | 193.82 | 147.276 | 92.148 | 51.339 | 57.783 | 45.745 | 49.83 | 37.053 |
| Other Non-Current Liabilities
| -182.006 | 5.334 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 355.955 | 549.596 | 614.192 | 467.728 | 476.172 | 473.802 | 404.616 | 134.815 | 133.99 | 89.814 |
| Total Liabilities
| 1,681.421 | 2,616.522 | 2,252.784 | 1,932.97 | 1,096.547 | 1,578.502 | 1,174.064 | 879.105 | 854.018 | 1,008.856 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 633.265 | 633.265 | 633.265 | 633.265 | 422.177 | 374.177 | 374.177 | 374.177 | 358.66 | 340.424 |
| Retained Earnings
| 1,724.21 | 1,685.813 | 1,455.085 | 1,599.838 | 761.271 | 515.36 | 319.767 | 230.593 | 345.95 | 305.337 |
| Accumulated Other Comprehensive Income/Loss
| 278.491 | 230.73 | 113.34 | 126.335 | 105.896 | 93.406 | 394.036 | 402.683 | 277.016 | 0 |
| Other Total Stockholders Equity
| 551.262 | 551.262 | 551.262 | 551.262 | 762.351 | 329.654 | 0 | 0 | 0 | 79.379 |
| Total Shareholders Equity
| 3,187.229 | 3,101.071 | 2,752.953 | 2,910.701 | 2,051.695 | 1,312.596 | 1,087.979 | 1,007.453 | 981.625 | 725.14 |
| Total Equity
| 3,210.96 | 3,130.985 | 2,752.045 | 2,923.111 | 2,059.169 | 1,321.685 | 1,098.539 | 1,018.438 | 994.18 | 742.076 |
| Total Liabilities & Shareholders Equity
| 5,084.318 | 5,747.507 | 5,004.829 | 4,856.08 | 3,155.716 | 2,900.187 | 2,272.602 | 1,897.544 | 1,848.198 | 1,750.932 |